0001209191-17-029168.txt : 20170502
0001209191-17-029168.hdr.sgml : 20170502
20170502160344
ACCESSION NUMBER: 0001209191-17-029168
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170501
FILED AS OF DATE: 20170502
DATE AS OF CHANGE: 20170502
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AGIOS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001439222
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 88 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-649-8600
MAIL ADDRESS:
STREET 1: 88 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schenkein David P
CENTRAL INDEX KEY: 0001578200
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36014
FILM NUMBER: 17804953
MAIL ADDRESS:
STREET 1: C/O BLUEBIRD BIO, INC.
STREET 2: 840 MEMORIAL DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-05-01
0
0001439222
AGIOS PHARMACEUTICALS INC
AGIO
0001578200
Schenkein David P
C/O AGIOS PHARMACEUTICALS, INC.
88 SIDNEY STREET
CAMBRIDGE
MA
02139
1
1
0
0
Chief Executive Officer
Common stock
2017-05-01
4
M
0
3000
0.3025
A
3000
D
Common stock
2017-05-01
4
S
0
3000
50.06
D
0
D
Common stock
272272
I
See footnote
Common stock
79082
I
See footnote
Stock option (right to buy)
0.3025
2017-05-01
4
M
0
3000
0.00
D
2019-08-12
Common stock
3000
192656
D
This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $50.00 to $50.17. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Shares held by David P. Schenkein 2004 Revocable Trust, of which the reporting person is trustee and beneficiary.
Shares held by Amy P. Schenkein 2004 Revocable Trust, of which the reporting person's spouse is trustee and beneficiary.
This option was granted on August 13, 2009. The shares underlying this option vest as to 25% of the shares on August 1, 2010, with the remaining 75% vesting in 36 equal monthly installments thereafter.
/s/ Andrew Hirsch, as Attorney-in-Fact for David Schenkein
2017-05-02